U Theuretzbacher
Overview
Explore the profile of U Theuretzbacher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kristoffersson A, Rognas V, Brill M, Dishon-Benattar Y, Durante-Mangoni E, Daitch V, et al.
Clin Microbiol Infect
. 2020 Mar;
26(12):1644-1650.
PMID: 32213316
Objectives: The aim was to analyse the population pharmacokinetics of colistin and to explore the relationship between colistin exposure and time to death. Methods: Patients included in the AIDA randomized...
2.
Theuretzbacher U, Paul M
Clin Microbiol Infect
. 2018 Aug;
24(12):1231-1233.
PMID: 30076976
No abstract available.
3.
Theuretzbacher U
Clin Microbiol Infect
. 2017 Aug;
23(10):695-696.
PMID: 28830808
No abstract available.
4.
Theuretzbacher U
Clin Microbiol Infect
. 2017 Jun;
23(10):713-717.
PMID: 28652114
Background: The public health threat of antibiotic resistance has gained attention at the highest political levels globally, and recommendations on how to respond are being considered for implementation. Among the...
5.
Tangden T, Ramos Martin V, Felton T, Nielsen E, Marchand S, Bruggemann R, et al.
Intensive Care Med
. 2017 Apr;
43(7):1021-1032.
PMID: 28409203
Critically ill patients with severe infections are at high risk of suboptimal antimicrobial dosing. The pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials in these patients differ significantly from the patient...
6.
Huttner A, Leibovici L, Theuretzbacher U, Huttner B, Paul M
Clin Microbiol Infect
. 2016 Aug;
23(2):73-77.
PMID: 27497812
The informed consent document is intended to provide basic rights to patients but often fails to do so. Patients' autonomy may be diminished by virtue of their illness; evidence shows...
7.
Theuretzbacher U, Paul M
Clin Microbiol Infect
. 2015 Jun;
21(10):878-80.
PMID: 26119721
No abstract available.
8.
Muller A, Theuretzbacher U, Mouton J
Clin Microbiol Infect
. 2015 Jun;
21(10):881-5.
PMID: 26093075
Because of the increase in bacterial resistance to commonly used antibacterial drugs, old antibiotics are being 'revived' and, once again, are attracting interest. Many of these old antibiotics were approved...
9.
Harbarth S, Theuretzbacher U, Hackett J
J Antimicrob Chemother
. 2015 Feb;
70(6):1604-7.
PMID: 25673635
The global burden of antibiotic resistance is tremendous and, without new anti-infective strategies, will continue to increase in the coming decades. Despite the growing need for new antibiotics, few pharmaceutical...
10.
Theuretzbacher U
Eur J Clin Microbiol Infect Dis
. 2004 Oct;
23(11):805-12.
PMID: 15490294
The novel class of echinocandins represents a milestone in antifungal drug research that has further expanded our therapeutic options. The favorable pharmacokinetic profile of the echinocandins has been elucidated in...